Page 29 - Anjali Singh

Tyre manufacturers Ceat and Apollo to hike prices as input costs soar

Crude prices, which hovered around $88 to 90 over the past three months, represent a 6 to 8 per cent increase from the previous quarter, adding further strain on manufacturers' margins

Zydus, MSN partner to license, supply affordable cancer tablets in the US

MSN Lab will manufacture and supply Cabozantinib; Zydus will handle marketing, distribution and sales

GSK's Shingrix vaccine can prevent shingles for over a decade: Study

Shingles is a painful rash caused by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. Up to one in three people will develop shingles in their lifetime

Zydus Wellness Q4 profit up 3.4%, driven by strong brand performance

For the full year of FY24, the company posted a 14 per cent Y-o-Y decline in PAT and the revenue grew by 3.2 per cent reaching Rs 266.9 crore and Rs 2,327.8 crore respectively

Eicher Motors' Q4 PAT rises 18%, Royal Enfield sales hit record high

On a sequential basis, the company's PAT rose 7.48%, while the revenue rose by 1.85%

Piramal Pharma Q4 profit Jumps 102% to Rs 101.3 cr, FY24 revenue Up 18%

On a sequential basis, the company's profit jumped more than nine-fold

Ceat plans to revamp brand strategy to target SUV owners, adventure bikers

Ceat plans to reach its target audience through various touchpoints

Dr Lal PathLabs Q4 results: Net profit jumps 49% to Rs 84.5 crore

Eyes expansion into Tier 3 and Tier 4 towns

Cipla Q4 results: Net profit soars 79% on strong India and US business

Eyes further market expansion and partnerships in FY25

AstraZeneca to withdraw Covid-19 vaccine Vaxzevria globally on weak demand

AstraZeneca will start the withdrawal of marketing authorisation for the vaccine in Europe

ICRA forecasts moderate growth for tyre sector in FY25 as input costs rises

The report cites healthy demand from OEMs in the passenger vehicle (PV) and two-wheeler (2W) segments, along with replacement demand, as the primary drivers of domestic growth

Dr Reddy's Labs Q4 profit jumps 36% led by US growth, new products

During the quarter, the company launched 5 new products, of which 4 were launched in the US. A total of 21 products were launched during the year

Wockhardt Hospitals launches early recovery program for liver transplant

The hospital group also claims that the ERP program improves the survival rate of the patients by approximately 2-3 per cent while enhancing patient outcomes through advanced techniques

Breathe easy! Philips says its sleep apnea devices safe for use in India

The company reached a $1.1 billion settlement for CPAP machine lawsuits in US

Covishield vaccine case: Plea filed in SC seeking probe on AstraZeneca

AstraZeneca, facing a lawsuit in UK for alleged vaccine-related deaths and injuries, has acknowledged that its vaccine can cause Thrombosis with Thrombocytopenia Syndrome (TTS)

Chromosome polymorphism a key factor in recurrent pregnancy loss: Study

The researchers caution that more studies are needed to solidify this link

Indegene sets IPO price band at Rs 430-452, aims to raise Rs 1,842 crore

In financial year 2023, Indegene reported Rs 2,306.13 crore in revenue from operations with a profit of Rs 266 crore

CII-IGBC expects surge in private capex, FDI after Lok Sabha polls

It says top priority for new govt should be to strike balance between economic growth and environmental sustainability

Dr Basu Eye Hospital plans to open five new hospitals in India in 5 years

The hospital claims that the costs of their treatments are significantly lower compared to traditional surgeries and modern medical treatments

Glenmark Life Sciences Q4 results: Profit dips 33.62% to Rs 97.93 crore

For the fiscal year 2023-2024, Glenmark Life Sciences reported revenue from operations of Rs 2,283.2 crore, marking a growth of 5.6 per cent year-over-year (Y-o-Y)